InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Jimenez Freddy A., SVP & Conseiller Juridique. Director active across 1 company, notably Celldex Therapeutics, Inc.. In total, 5 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €34k. History available since 11 August 2021. The latest transaction was disclosed on 5 June 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
9,540 shares@ US$10.3838.6% of flowCommon StockSEC:0001415889-24-015950:0
8,006 shares@ US$10.3832.3% of flowCommon StockSEC:0001415889-24-015542:0
4,166 shares@ US$9.016514.8% of flowCommon StockSEC:0001415889-24-003891:0
430 shares@ US$46.287.2% of flowCommon StockSEC:0001179110-21-008163
Ideal exit: 8 May 2022 (T+270)
430 shares@ US$46.280.0007% mcap50.0% of flowCommon StockSEC:0001179110-21-008163:0
Ideal exit: 8 May 2022 (T+270)
5 of 5 declarations
About Jimenez Freddy A.
Freddy A. Jimenez is the Senior Vice President and General Counsel of Celldex Therapeutics, Inc. He oversees the legal affairs of the company, ensuring regulatory compliance and protecting the legal interests of Celldex. His expertise in business law is essential for navigating the complex legal landscape of the industry.
